A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, ...

Even with breakthroughs, treatment for advanced squamous cell carcinoma is more complex. Patients often need more than one treatment. Many patients with this advanced cancer are cared for by a team of ...

Colleen Mabasa, a patient with multiple myeloma, discusses her CAR T-cell therapy journey and the pivotal role self-advocacy ...

Patients treated in an outpatient setting who later required admission spent an average of 12.1 days in the hospital, ...

Some parts of our bodies bounce back from injury in fairly short order. The outer protective layer of the eye—called the ...

For years, cell and gene therapies were mainly associated with rare and orphan diseases, those that impact small patient groups and lack effective treatment options. However, recent developments in ...

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond Street Hospital (GOSH), has shown promising results in ...

What is the outlook for someone who has squamous cell carcinoma of the skin? The outlook is excellent when found early and properly treated. More than 90% of patients are cured. FDA-approved ...

Lumacyte CEO on how real-time insight is driving down manufacturing failures and opening doors for more patients.